Protein isoprenylation in biology and disease: General overview and perspectives from studies with genetically engineered animals

Frontiers in Bioscience

Volumn 12, Issue 12, 2007, Pages 4456-4472

  Perez Sala, Dolores ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

Animal models; Genetic disruption; Isoprenylation; Ras proteins; Review; Statins

Indexed keywords

ANIMALIA;

DIMETHYLALLYLTRANSFERASE;

ANIMAL; METABOLISM; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DIMETHYLALLYLTRANSTRANSFERASE; PROTEIN ISOPRENYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION;

EID: 34347218222     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2401     Document Type: Review

References (171)

1. Melkonian, K. A., A. G. Ostermeyer, J. Z. Chen, M. G. Roth & D. A. Brown: Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts. Many raft proteins are acylated, while few are prenylated. J Biol Chem, 274, 3910-3917 (1999) (Pubitemid 29077242)
2. Scheffzek, K., I. Stephan, O. N. Jensen, D. Illenberger & P. Gierschik: The Rac-RhoGDI complex and the structural basis for the regulation of Rho proteins by RhoGDI. Nat Struct Biol, 7, 122-126 (2000) (Pubitemid 30082509)
3. Hancock, J. F., K. Cadwallader, H. Paterson & C. J. Marshall: A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins. EMBO J, 10, 4033-4039 (1991) (Pubitemid 21905433)
4. Rocks, O., A. Peyker, M. Kahms, P. J. Verveer, C. Koerner, M. Lumbierres, J. Kuhlmann, H. Waldmann, A. Wittinghofer & P. I. Bastiaens: An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science, 307, 1746-1752 (2005) (Pubitemid 40388611)
5. Qanbar, R. & M. Bouvier: Role of palmitoylation/depalmitoylation reactions in G-proteincoupled receptor function. Pharmacol Ther, 97, 1-33 (2003) (Pubitemid 35477802)
6. Paz, A., R. Haklai, G. Elad-Sfadia, E. Ballan & Y. Kloog: Galectin-1 binds H-ras to mediate Ras membrane anchorage and cell transformation. Oncogene, 20, 7486-7493 (2001) (Pubitemid 33086908)
7. Sinensky, M.: Functional aspects of polyisoprenoid protein substituents: roles in protein-protein interaction and trafficking. Biochim Biophys Acta, 1529, 203-209 (2000)
8. Resh, M. D.: Trafficking and signaling by fatty-acylated and prenylated proteins. Nat Chem Biol, 2, 584-590 (2006) (Pubitemid 44610342)
9. Vesa, J., E. Hellsten, L. A. Verkruyse, L. A. Camp, J. Rapola, P. Santavuori, S. L. Hofmann & L. Peltonen: Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature, 376, 584-587 (1995)
10. Pereira-Leal, J. B., A. N. Hume & M. C. Seabra: Prenylation of Rab GTPases: molecular mechanisms and involvement in genetic disease. FEBS Lett, 498, 197-200 (2001) (Pubitemid 32539202)
11. Blum, R. & Y. Kloog: Tailoring Ras-pathway-inhibitor combinations for cancer therapy. Drug Resist Updat, 8, 369-380 (2005) (Pubitemid 43358060)
12. Winter-Vann, A. M. & P. J. Casey: Post-prenylationprocessing enzymes as new targets in oncogenesis. Nat Rev Cancer, 5, 405-412 (2005) (Pubitemid 40637832)
13. Hernández-Perera, O., D. Pérez-Sala, E. Soria & S. Lamas: Involvement of Rho GTPases in the transcriptional inhibition of pre-proendothelin-1 gene expression by Simvastatin in vascular endothelial cells. Circ. Res., 87, 616-622 (2000)
14. Rikitake, Y. & J. K. Liao: Rho GTPases, statins, and nitric oxide. Circ Res, 97, 1232-1235 (2005)
15. Petersen, D. R. & J. A. Doorn: Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med, 37, 937-945 (2004) (Pubitemid 39164576)
16. Murray, I., L. Liu, H. Komatsu, K. Uryu, G. Xiao, J. Lawson & P. Axelsen: Membrane mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins. J Biol Chem, In press, (2007)
17. Goldstein, J. L. & M. S. Brown: Regulation of the mevalonate pathway. Nature, 343, 425-430 (1990)
18. Maltese, W. A. & K. M. Sheridan: Differentiation of neuroblastoma cells induced by an inhibitor of mevalonate synthesis: relation of neurite outgrowth and acetylcholinesterase activity to changes in cell proliferation and blocked isoprenoid synthesis. J Cell Physiol, 125, 540-558 (1985) (Pubitemid 16200954)
19. Maltese, W. A. & K. M. Sheridan: Isoprenylated proteins in cultured cells: subcellular distribution and changes related to altered morphology and growth arrest induced by mevalonate deprivation. J Cell Physiol, 133, 471-481 (1987) (Pubitemid 18014257)
20. Beck, L. A., T. J. Hosick & M. Sinensky: Incorporation of a product of mevalonic acid metabolism into proteins of Chinese hamster ovary cell nuclei. J Cell Biol, 107, 1307-1316 (1988)
21. Jackson, J. H., C. G. Cochrane, J. R. Bourne, P. A. Solski, J. E. Buss & C. J. Der: Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation. Proc Natl Acad Sci U S A, 87, 3042-3046 (1990)
22. Mumby, S. M., P. J. Casey, A. G. Gilman, S. Gutowski & P. C. Sternweis: G protein gamma subunits contain a 20-carbon isoprenoid. Proc Natl Acad Sci U S A, 87, 5873-5877 (1990)
23. Maltese, W. A.: Posttranslational modification of proteins by isoprenoids in mammalian cells. Faseb J, 4, 3319-3328 (1990) (Pubitemid 120012579)
24. Sinensky, M.: Recent advances in the study of prenylated proteins. Biochim Biophys Acta, 1484, 93-106 (2000) (Pubitemid 30175960)
25. Hancock, J. F., A. I. Magee, J. E. Childs & C. J. Marshall: All ras proteins are polyisoprenylated but only some are palmitoylated. Cell, 57, 1167-1177 (1989) (Pubitemid 19169813)
26. Kinsella, B. T. & W. A. Maltese: rab GTP-binding proteins with three different carboxyl-terminal cysteine motifs are modified in vivo by 20-carbon isoprenoids. J Biol Chem, 267, 3940-3945 (1992)
27. Vorburger, K., G. T. Kitten & E. A. Nigg: Modification of nuclear lamin proteins by a mevalonic acid derivative occurs in reticulocyte lysates and requires the cysteine residue of the C-terminal CXXM motif EMBO J, 8, 4007-4013 (1989) (Pubitemid 20066841)
28. Inglese, J., J. F. Glickman, W. Lorenz, M. G. Caron & R. J. Lefkowitz: Isoprenylation of a protein kinase. Requirement of farnesylation/alpha-carboxyl methylation for full enzymatic activity of rhodopsin kinase. J Biol Chem, 267, 1422-1425 (1992)
29. Lai, R. K., D. Pérez-Sala, F. J. Cañada & R. R. Rando: The □ subunit of transducin is farnesylated. Proc Natl Acad Sci USA, 87, 7673-7677 (1990)
30. Fukada, Y., T. Takao, H. Ohguro, T. Yoshizawa, T. Akino & Y. Shimonishi: Farnesylated gamma-subunit of photoreceptor G protein indispensable for GTP-binding. Nature, 346, 658-660 (1990)
31. Kitten, G. T. & E. A. Nigg: The CaaX motif is required for isoprenylation, carboxyl methylation, and nuclear membrane association of lamin B2. J Cell Biol, 113, 13-23 (1991) (Pubitemid 21909669)
32. Spiegel, A. M., P. S. Backlund, Jr., J. E. Butrynski, T. L. Jones & W. F. Simonds: The G protein connection: molecular basis of membrane association. Trends Biochem Sci, 16, 338-341 (1991) (Pubitemid 121004466)
33. Takai, Y., K. Kaibuchi, A. Kikuchi, T. Sasaki & H. Shirataki: Regulators of small GTPases. Ciba Found Symp, 176, 128-138; discussion 138-146 (1993)
34. Grizot, S., J. Faure, F. Fieschi, P. V. Vignais, M. C. Dagher & E. Pebay-Peyroula: Crystal structure of the Rac1-RhoGDI complex involved in nadph oxidase activation. Biochemistry, 40, 10007-10013 (2001) (Pubitemid 32800107)
35. Dransart, E., B. Olofsson & J. Cherfils: RhoGDIs revisited: novel roles in Rho regulation. Traffic, 6, 957-966 (2005) (Pubitemid 41472455)
36. Fivaz, M. & T. Meyer: Reversible intracellular translocation of KRas but not HRas in hippocampal neurons regulated by Ca2+/calmodulin. J Cell Biol, 170, 429-441 (2005) (Pubitemid 41126942)
37. Stamatakis, K., E. Cernuda-Morollón, O. Hernández-Perera & D. Pérez-Sala: Isoprenylation of RhoB is required for its degradation: a novel determinant in the complex regulation of RhoB expression by the mevalonate pathway. J. Biol. Chem., 277, 49389-49396 (2002) (Pubitemid 36014371)
38. Parish, C. A. & R. R. Rando: Isoprenylation/methylation of proteins enhances membrane association by a hydrophobic mechanism. Biochemistry, 35, 8473-8477 (1996)
39. Lane, K. T. & L. S. Beese: Structural biology of protein farnesyltransferase and geranylgeranyltransferase type I. J Lipid Res, 47, 681-699 (2006)
40. Leung, K. F., R. Baron & M. C. Seabra: Geranylgeranylation of Rab GTPases. J Lipid Res, 47, 467-475 (2006) (Pubitemid 43345587)
41. Whyte, D. B., P. Kirschmeier, T. N. Hockenberry, I. Nunez-Oliva, L. James, J. J. Catino, W. R. Bishop & J. K. Pai: K-and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors. J Biol Chem, 272, 14459-14464 (1997) (Pubitemid 27232866)
42. Basso, A. D., P. Kirschmeier & W. R. Bishop: Farnesyl transferase inhibitors. J Lipid Res, 47, 15-31 (2006) (Pubitemid 43107445)
43. Adamson, P., C. J. Marshall, A. Hall & P. A. Tilbrook: Post-translational modifications of p21rho proteins. J Biol Chem, 267, 20033-20038 (1992)
44. Lebowitz, P. F., P. J. Casey, G. C. Prendergast & J. A. Thissen: Farnesyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoB. J Biol Chem, 272, 15591-15594 (1997) (Pubitemid 27265524)
45. Du, W., P. F. Lebowitz & G. C. Prendergast: Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB. Mol Cell Biol, 19, 1831-1840 (1999) (Pubitemid 29098241)
46. Andres, D. A., M. C. Seabra, M. S. Brown, S. A. Armstrong, T. E. Smeland, F. P. Cremers & J. L. Goldstein: cDNA cloning of component A of Rab geranylgeranyl transferase and demonstration of its role as a Rab escort protein. Cell, 73, 1091-1099 (1993) (Pubitemid 23180484)
47. Seabra, M. C., Y. Reiss, P. J. Casey, M. S. Brown & J. L. Goldstein: Protein farnesyltransferase and geranylgeranyltransferase share a common alpha subunit. Cell, 65, 429-434 (1991) (Pubitemid 121002052)
48. Reiss, Y., M. C. Seabra, S. A. Armstrong, C. A. Slaughter, J. L. Goldstein & M. S. Brown: Nonidentical subunits of p21H-ras farnesyltransferase. Peptide binding and farnesyl pyrophosphate carrier functions. J Biol Chem, 266, 10672-10677 (1991) (Pubitemid 21906854)
49. Taylor, J. S., T. S. Reid, K. L. Terry, P. J. Casey & L. S. Beese: Structure of mammalian protein geranylgeranyltransferase type-I. EMBO J, 22, 5963-5974 (2003) (Pubitemid 37463240)
50. Reid, T. S., K. L. Terry, P. J. Casey & L. S. Beese: Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity. J Mol Biol, 343, 417-433 (2004) (Pubitemid 39296875)
51. Pylypenko, O., A. Rak, R. Reents, A. Niculae, V. Sidorovitch, M. D. Cioaca, E. Bessolitsyna, N. H. Thoma, H. Waldmann, I. Schlichting, R. S. Goody & K. Alexandrov: Structure of Rab escort protein-1 in complex with Rab geranylgeranyltransferase. Mol Cell, 11, 483-494 (2003) (Pubitemid 36293840)
52. He, B., P. Chen, S. Y. Chen, K. L. Vancura, S. Michaelis & S. Powers: RAM2, an essential gene of yeast, and RAM1 encode the two polypeptide components of the farnesyltransferase that prenylates a-factor and Ras proteins. Proc Natl Acad Sci U S A, 88, 11373-11377 (1991) (Pubitemid 21916043)
53. Vallim, M. A., L. Fernandes & J. A. Alspaugh: The RAM1 gene encoding a protein-farnesyltransferase betasubunit homologue is essential in Cryptococcus neoformans. Microbiology, 150, 1925-1935 (2004) (Pubitemid 38923690)
54. Yalovsky, S., A. Kulukian, M. Rodriguez-Concepcion, C. A. Young & W. Gruissem: Functional requirement of plant farnesyltransferase during development in Arabidopsis. Plant Cell, 12, 1267-1278 (2000)
55. Powers, S., S. Michaelis, D. Broek, S. Santa Anna, J. Field, I. Herskowitz & M. Wigler: RAM, a gene of yeast required for a functional modification of RAS proteins and for production of mating pheromone a-factor. Cell, 47, 413-422 (1986) (Pubitemid 17210155)
56. Schafer, W. R., R. Kim, R. Sterne, J. Thorner, S.-H. Kim & J. Rine: Genetic and pharmacological suppression of oncogenic ras mutations in yeast and humans. Science, 245, 379-385 (1989) (Pubitemid 19203359)
57. Mijimolle, N., J. Velasco, P. Dubus, C. Guerra, C. A. Weinbaum, P. J. Casey, V. Campuzano & M. Barbacid: Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor development. Cancer Cell, 7, 313-324 (2005) (Pubitemid 40544649)
58. Larijani, B., A. N. Hume, A. K. Tarafder & M. C. Seabra: Multiple factors contribute to inefficient prenylation of Rab27a in Rab prenylation diseases. J Biol Chem, 278, 46798-46804 (2003) (Pubitemid 37452259)
59. Shotelersuk, V. & W. A. Gahl: Hermansky-Pudlak syndrome: models for intracellular vesicle formation. Mol Genet Metab, 65, 85-96 (1998) (Pubitemid 28507129)
60. Cremers, F. P., D. J. van de Pol, L. P. van Kerkhoff, B. Wieringa & H. H. Ropers: Cloning of a gene that is rearranged in patients with choroideraemia. Nature, 347, 674-677 (1990)
61. Tolmachova, T., R. Anders, M. Abrink, L. Bugeon, M. J. Dallman, C. E. Futter, J. S. Ramalho, F. Tonagel, N. Tanimoto, M. W. Seeliger, C. Huxley & M. C. Seabra: Independent degeneration of photoreceptors and retinal pigment epithelium in conditional knockout mouse models of choroideremia. J Clin Invest, 116, 386-394 (2006) (Pubitemid 43228355)
62. Buckner, F. S., R. T. Eastman, K. Yokoyama, M. H. Gelb & W. C. Van Voorhis: Protein farnesyl transferase inhibitors for the treatment of malaria and African trypanosomiasis. Curr Opin Investig Drugs, 6, 791-797 (2005) (Pubitemid 41103039)
63. Eastman, R. T., F. S. Buckner, K. Yokoyama, M. H. Gelb & W. C. Van Voorhis: Thematic review series: lipid posttranslational modifications. Fighting parasitic disease by blocking protein farnesylation. J Lipid Res, 47, 233-240 (2006)
64. Hernández-Perera, O., D. Pérez-Sala, R. Sánchez-Pascuala, J. Navarro-Antolín, G. Hernández, C. Díaz & S. Lamas: Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J. Clin. Invest., 101, 2711-2719 (1998) (Pubitemid 28294580)
65. Lahera, V., M. Goicoechea, S. G. de Vinuesa, M. Miana, N. de Las Heras, V. Cachofeiro & J. Luno: Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins. Curr Med Chem, 14, 243-248 (2007) (Pubitemid 46043919)
66. Laufs, U., M. Endress, F. Custodis, K. Gertz, G. Nickenig, J. K. Liao & M. Böhm: Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of Rho GTPase gene transcription. Circulation, 102, 3104-3110 (2000)
67. Laufs, U. & J. K. Liao: Targeting Rho in cardiovascular disease. Circ. Res., 87, 526-528 (2000)
68. Laufs, U., V. L. Fata & J. K. Liao: Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. J Biol Chem, 272, 31725-31729 (1997) (Pubitemid 28013321)
69. Endres, M., U. Laufs, Z. Huang, T. Nakamura, P. Huang, M. A. Moskowitz & J. K. Liao: Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci U S A, 95, 8880-8885 (1998) (Pubitemid 28350583)
70. Laufs, U., D. Marra, K. Node & J. Liao: 3-Hydroxy-3-methylglutaryl- CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing Rho GTPaseinduced down-regulation of p27Kip1. J. Biol. Chem, 274, 21926-21931 (1999)
71. Arnaud, C., N. R. Veillard & F. Mach: Cholesterolindependent effects of statins in inflammation, immunomodulation and atherosclerosis. Curr Drug Targets Cardiovasc Haematol Disord, 5, 127-134 (2005) (Pubitemid 40645486)
72. Miida, T., A. Takahashi & T. Ikeuchi: Prevention of stroke and dementia by statin therapy: Experimental and clinical evidence of their pleiotropic effects. Pharmacol Ther, 113, 378-393 (2007) (Pubitemid 46149052)
73. Pérez-Sala, D. & F. Mollinedo: Inhibition of isoprenoid biosynthesis induces apoptosis in human promyelocytic HL-60 cells. Biochem. Biophys. Res. Commun., 199, 1209-1215 (1994) (Pubitemid 24174787)
74. Jones, K. D., W. T. Couldwell, D. R. Hinton, Y. Su, S. He, L. Anker & R. E. Law: Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells. Biochem Biophys Res Commun, 205, 1681-1687 (1994)
75. Katz, M. S.: Therapy insight: Potential of statins for cancer chemoprevention and therapy. Nat Clin Pract Oncol, 2, 82-89 (2005) (Pubitemid 40790141)
76. Fritz, G.: HMG-CoA reductase inhibitors (statins) as anticancer drugs (review). Int J Oncol, 27, 1401-1409 (2005)
77. Russell, R. G. & M. J. Rogers: Bisphosphonates: from the laboratory to the clinic and back again. Bone, 25, 97-106 (1999) (Pubitemid 29322070)
78. Roelofs, A. J., K. Thompson, S. Gordon & M. J. Rogers: Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res, 12, 6222s-6230s (2006) (Pubitemid 44703794)
79. Fleisch, H. A., R. G. Russell, S. Bisaz, R. C. Muhlbauer & D. A. Williams: The inhibitory effect of phosphonates on the formation of calcium phosphate crystals in vitro and on aortic and kidney calcification in vivo. Eur J Clin Invest, 1, 12-18 (1970)
80. Van Beek, E., E. Pieterman, L. Cohen, C. Lowik & S. Papapoulos: Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates. Biochem Biophys Res Commun, 264, 108-111 (1999) (Pubitemid 29500472)
81. Rondeau, J. M., F. Bitsch, E. Bourgier, M. Geiser, R. Hemmig, M. Kroemer, S. Lehmann, P. Ramage, S. Rieffel, A. Strauss, J. R. Green & W. Jahnke: Structural basis for the exceptional in vivo efficacy of bisphosphonate drugs. ChemMedChem, 1, 267-273 (2006) (Pubitemid 43700307)
82. Coxon, F. P., K. Thompson & M. J. Rogers: Recent advances in understanding the mechanism of action of bisphosphonates. Curr Opin Pharmacol, 6, 307-312 (2006) (Pubitemid 43670914)
83. Leung, K. F., R. Baron, B. R. Ali, A. I. Magee & M. C. Seabra: Rab GTPases containing a CAAX motif are processed post-geranylgeranylation by proteolysis and methylation. J Biol Chem, 282, 1487-1497 (2007) (Pubitemid 47076530)
84. Ma, Y. T. & R. R. Rando: A microsomal endoprotease that specifically cleaves isoprenylated peptides. Proc Natl Acad Sci U S A, 89, 6275-6279 (1992)
85. Ma, Y. T., A. Chaudhuri & R. R. Rando: Substrate specificity of the isoprenylated protein endoprotease. Biochemistry, 31, 11772-11777 (1992)
86. Tan, E. W., D. Pérez-Sala, F. J. Cañada & R. R. Rando: Identifying the recognition unit for G protein methylation. J. Biol. Chem., 266, 10719-10722 (1991) (Pubitemid 21906861)
87. Gilbert, B. A., E. W. Tan, D. Pérez-Sala & R. R. Rando: Structure-activity studies on the retinal rod outer segment isoprenylated protein methyltransferase. J. Am. Chem. Soc., 114, 3996-3973 (1992)
88. Pérez-Sala, D., B. A. Gilbert, E. W. Tan & R. R. Rando: Prenylated protein methyltransferases do not distinguish between farnesylated and geranylgeranylated substrates. Biochem. J., 284, 835-840 (1992)
89. Pérez-Sala, D., E. W. Tan, F. J. Cañada & R. R. Rando: Methylation and demethylation reactions of guanine nucleotide-binding proteins of retinal rod outer segments. Proc Natl Acad Sci USA, 88, 3043-3046 (1991) (Pubitemid 21916554)
90. Chelsky, D., J. F. Olson & D. E. Koshland, Jr.: Cell cycle-dependent methyl esterification of lamin B. J Biol Chem, 262, 4303-4309 (1987)
91. Sobotka-Briner, C. & D. Chelsky: COOH-terminal methylation of lamin B and inhibition of methylation by farnesylated peptides corresponding to lamin B and other CAAX motif proteins. J Biol Chem, 267, 12116-12122 (1992)
92. Chiu, V. K., J. Silletti, V. Dinsell, H. Wiener, K. Loukeris, G. Ou, M. R. Philips & M. H. Pillinger: Carboxyl methylation of Ras regulates membrane targeting and effector engagement. J Biol Chem, 279, 7346-7352 (2004) (Pubitemid 38248885)
93. Tan, E. W. & R. R. Rando: Identification of an isoprenylated cysteine methyl ester hydrolase activity in bovine rod outer segment membranes. Biochemistry, 31, 5572-5578 (1992)
94. Van Dessel, G. A., H. M. De Busser & A. R. Lagrou: On the occurrence of multiple isoprenylated cysteine methyl ester hydrolase activities in bovine adrenal medulla. Biochem Biophys Res Commun, 284, 50-56 (2001) (Pubitemid 32924307)
95. Shi, Y. Q. & R. R. Rando: Kinetic mechanism of isoprenylated protein methyltransferase. J Biol Chem, 267, 9547-9551 (1992)
96. Marom, M., R. Haklai, G. Ben-Baruch, D. Marciano, Y. Egozi & Y. Kloog: Selective inhibition of rasdependent cell growth by farnesylthiosalisylic acid. J. Biol. Chem., 270, 22263-22270 (1995)
97. Ding, J., D. J. Lu, D. Pérez-Sala, Y. T. Ma, J. F. Maddox, B. A. Gilbert, J. A. Badwey & R. R. Rando: Farnesyl-L-cysteine analogs can inhibit or initiate superoxide release by human neutrophils. J. Biol. Chem, 269, 16837-16844 (1994) (Pubitemid 24200449)
98. Pérez-Sala, D., B. A. Gilbert, R. R. Rando & F. J. Cañada: Analogs of farnesylcysteine induce apoptosis in HL-60 cells. FEBS Lett., 426, 319-324 (1998) (Pubitemid 28218372)
99. Winter-Vann, A. M., R. A. Baron, W. Wong, J. dela Cruz, J. D. York, D. M. Gooden, M. O. Bergo, S. G. Young, E. J. Toone & P. J. Casey: A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells. Proc Natl Acad Sci U S A, 102, 4336-4341 (2005) (Pubitemid 40397112)
100. Otto, J. C., E. Kim, S. G. Young & P. J. Casey: Cloning and characterization of a mammalian prenyl protein-specific protease. J Biol Chem, 274, 8379-8382 (1999) (Pubitemid 29164625)
101. Dai, Q., E. Choy, V. Chiu, J. Romano, S. R. Slivka, S. A. Steitz, S. Michaelis & M. R. Philips: Mammalian prenylcysteine carboxyl methyltransferase is in the endoplasmic reticulum. J Biol Chem, 273, 15030-15034 (1998) (Pubitemid 28272797)
102. Boyartchuk, V. L., M. N. Ashby & J. Rine: Modulation of Ras and a-factor function by carboxylterminal proteolysis. Science, 275, 1796-800 (1997) (Pubitemid 27136718)
103. Hrycyna, C. A., S. K. Sapperstein, S. Clarke & S. Michaelis: The Saccharomyces cerevisiae STE14 gene encodes a methyltransferase that mediates C-terminal methylation of a-factor and RAS proteins. EMBO J, 10, 1699-1709 (1991) (Pubitemid 21905637)
104. Baron, R. A. & P. J. Casey: Analysis of the kinetic mechanism of recombinant human isoprenylcysteine carboxylmethyltransferase (Icmt). BMC Biochem, 5, 19 (2004)
105. Kim, E., P. Ambroziak, J. C. Otto, B. Taylor, M. Ashby, K. Shannon, P. J. Casey & S. G. Young: Disruption of the mouse Rce1 gene results in defective Ras processing and mislocalization of Ras within cells. J Biol Chem, 274, 8383-8390 (1999) (Pubitemid 29164626)
106. Bergo, M. O., G. K. Leung, P. Ambroziak, J. C. Otto, P. J. Casey, A. Q. Gomes, M. C. Seabra & S. G. Young: Isoprenylcysteine carboxyl methyltransferase deficiency in mice. J Biol Chem, 276, 5841-5845 (2001)
107. Lin, X., J. Jung, D. Kang, B. Xu, K. S. Zaret & H. Zoghbi: Prenylcysteine carboxylmethyltransferase is essential for the earliest stages of liver development in mice. Gastroenterology, 123, 345-351 (2002) (Pubitemid 34747554)
108. Bergo, M. O., G. K. Leung, P. Ambroziak, J. C. Otto, P. J. Casey & S. G. Young: Targeted inactivation of the isoprenylcysteine carboxyl methyltransferase gene causes mislocalization of K-Ras in mammalian cells. J Biol Chem, 275, 17605-17610 (2000) (Pubitemid 30430806)
109. Chen, Z., J. C. Otto, M. O. Bergo, S. G. Young & P. J. Casey: The C-terminal polylysine region and methylation of K-Ras are critical for the interaction between K-Ras and microtubules. J Biol Chem, 275, 41251-41257 (2000) (Pubitemid 32054958)
110. Bergo, M. O., P. Ambroziak, C. Gregory, A. George, J. C. Otto, E. Kim, H. Nagase, P. J. Casey, A. Balmain & S. G. Young: Absence of the CAAX endoprotease Rce1: effects on cell growth and transformation. Mol Cell Biol, 22, 171-181 (2002) (Pubitemid 33144266)
111. Aiyagari, A. L., B. R. Taylor, V. Aurora, S. G. Young & K. M. Shannon: Hematologic effects of inactivating the Ras processing enzyme Rce1. Blood, 101, 2250-2252 (2003) (Pubitemid 36302066)
112. Wahlstrom, A. M., B. A. Cutts, C. Karlsson, K. M. Andersson, M. Liu, A. K. Sjogren, B. Swolin, S. G. Young & M. O. Bergo: Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative disease. Blood, 109, 763-768 (2007) (Pubitemid 46105979)
113. Maske, C. P., M. S. Hollinshead, N. C. Higbee, M. O. Bergo, S. G. Young & D. J. Vaux: A carboxyl-terminal interaction of lamin B1 is dependent on the CAAX endoprotease Rce1 and carboxymethylation. J Cell Biol, 162, 1223-1232 (2003) (Pubitemid 37210879)
114. Michaelson, D., W. Ali, V. K. Chiu, M. Bergo, J. Silletti, L. Wright, S. G. Young & M. Philips: Postprenylation CAAX processing is required for proper localization of Ras but not Rho GTPases. Mol Biol Cell, 16, 1606-1616 (2005) (Pubitemid 40471934)
115. Bergo, M. O., H. D. Lieu, B. J. Gavino, P. Ambroziak, J. C. Otto, P. J. Casey, Q. M. Walker & S. G. Young: On the physiological importance of endoproteolysis of CAAX proteins: heart-specific RCE1 knockout mice develop a lethal cardiomyopathy. J Biol Chem, 279, 4729-4736 (2004) (Pubitemid 38199067)
116. Pendas, A. M., Z. Zhou, J. Cadinanos, J. M. Freije, J. Wang, K. Hultenby, A. Astudillo, A. Wernerson, F. Rodriguez, K. Tryggvason & C. Lopez-Otin: Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet, 31, 94-99 (2002)
117. Bergo, M. O., B. Gavino, J. Ross, W. K. Schmidt, C. Hong, L. V. Kendall, A. Mohr, M. Meta, H. Genant, Y. Jiang, E. R. Wisner, N. Van Bruggen, R. A. Carano, S. Michaelis, S. M. Griffey & S. G. Young: Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc Natl Acad Sci U S A, 99, 13049-13054 (2002)
118. Young, S. G., L. G. Fong & S. Michaelis: Prelamin A, Zmpste24, misshapen cell nuclei, and progeria-new evidence suggesting that protein farnesylation could be important for disease pathogenesis. J Lipid Res, 46, 2531-2558 (2005) (Pubitemid 43107466)
119. Scaffidi, P. & T. Misteli: Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nat Med, 11, 440-445 (2005) (Pubitemid 40562336)
120. Mallampalli, M. P., G. Huyer, P. Bendale, M. H. Gelb & S. Michaelis: Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA, 102, 14416-14421 (2005) (Pubitemid 41429712)
121. Cadinanos, J., I. Varela, C. Lopez-Otin & J. M. Freije: From immature lamin to premature aging: molecular pathways and therapeutic opportunities. Cell Cycle, 4, 1732-1735 (2005) (Pubitemid 41827315)
122. Varela, I., J. Cadinanos, A. M. Pendas, A. Gutierrez-Fernandez, A. R. Folgueras, L. M. Sanchez, Z. Zhou, F. J. Rodriguez, C. L. Stewart, J. A. Vega, K. Tryggvason, J. M. Freije & C. Lopez-Otin: Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature, 437, 564-568 (2005) (Pubitemid 41613555)
123. Scaffidi, P. & T. Misteli: Lamin A-dependent nuclear defects in human aging. Science, 312, 1059-1063 (2006)
124. Ramirez, C. L., J. Cadinanos, I. Varela, J. M. Freije & C. Lopez-Otin: Human progeroid syndromes, aging and cancer: new genetic and epigenetic insights into old questions. Cell Mol Life Sci, 64, 155-170 (2007) (Pubitemid 46156885)
125. Lobo, S., W. K. Greentree, M. E. Linder & R. J. Deschenes: Identification of a Ras palmitoyltransferase in Saccharomyces cerevisiae. J Biol Chem, 277, 41268-41273 (2002) (Pubitemid 35215719)
126. Roth, A. F., Y. Feng, L. Chen & N. G. Davis: The yeast DHHC cysteine-rich domain protein Akr1p is a palmitoyl transferase. J Cell Biol, 159, 23-28 (2002) (Pubitemid 35191514)
127. Swarthout, J. T., S. Lobo, L. Farh, M. R. Croke, W. K. Greentree, R. J. Deschenes & M. E. Linder: DHHC9 and GCP16 constitute a human protein fatty acyltransferase with specificity for H-and N-Ras. J Biol Chem, 280, 31141-31148 (2005) (Pubitemid 41291850)
128. Mitchell, D. A., A. Vasudevan, M. E. Linder & R. J. Deschenes: Protein palmitoylation by a family of DHHC protein S-acyltransferases. J Lipid Res, 47, 1118-1127 (2006) (Pubitemid 43830703)
129. Chamoun, Z., R. K. Mann, D. Nellen, D. P. von Kessler, M. Bellotto, P. A. Beachy & K. Basler: Skinny hedgehog, an acyltransferase required for palmitoylation and activity of the hedgehog signal. Science, 293, 2080-2084 (2001) (Pubitemid 32848055)
130. Gubitosi-Klug, R. A., D. J. Mancuso & R. W. Gross: The human Kv1.1 channel is palmitoylated, modulating voltage sensing: Identification of a palmitoylation consensus sequence. Proc Natl Acad Sci USA, 102, 5964-5968 (2005) (Pubitemid 40594238)
131. Robinson, L. J., L. Busconi & T. Michel: Agonistmodulated palmitoylation of endothelial nitric oxide synthase. J Biol Chem, 270, 995-998 (1995)
132. Navarro-Lerida, I., M. M. Corvi, A. A. Barrientos, F. Gavilanes, L. G. Berthiaume & I. Rodriguez-Crespo: Palmitoylation of inducible nitric-oxide synthase at Cys-3 is required for proper intracellular traffic and nitric oxide synthesis. J Biol Chem, 279, 55682-55689 (2004) (Pubitemid 40066573)
133. Ovchinnikov Yu. A., N. G. Abdulaev & A. S. Bogachuk: Two adjacent cysteine residues in the C-terminal cytoplasmic fragment of bovine rhodopsin are palmitylated. FEBS Lett, 230, 1-5 (1988) (Pubitemid 18089735)
134. O'Dowd, B. F., M. Hnatowich, M. G. Caron, R. J. Lefkowitz & M. Bouvier: Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. J Biol Chem, 264, 7564-7569 (1989) (Pubitemid 19119173)
135. Lee, H., S. E. Woodman, J. A. Engelman, D. Volonte, F. Galbiati, H. L. Kaufman, D. M. Lublin & M. P. Lisanti: Palmitoylation of caveolin-1 at a single site (Cys-156) controls its coupling to the c-Src tyrosine kinase: targeting of dually acylated molecules (GPI-linked, transmembrane, or cytoplasmic) to caveolae effectively uncouples c-Src and caveolin-1 (TYR-14). J Biol Chem, 276, 35150-35158 (2001)
136. Acconcia, F., P. Ascenzi, A. Bocedi, E. Spisni, V. Tomasi, A. Trentalance, P. Visca & M. Marino: Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. Mol Biol Cell, 16, 231-237 (2005) (Pubitemid 40028339)
137. Resh, M. D.: Palmitoylation of ligands, receptors, and intracellular signaling molecules. Sci STKE, 2006, re14 (2006)
138. Drisdel, R. C. & W. N. Green: Labeling and quantifying sites of protein palmitoylation. Biotechniques, 36, 276-285 (2004) (Pubitemid 38174735)
139. Roth, A. F., J. Wan, A. O. Bailey, B. Sun, J. A. Kuchar, W. N. Green, B. S. Phinney, J. R. Yates, 3rd & N. G. Davis: Global analysis of protein palmitoylation in yeast. Cell, 125, 1003-1013 (2006) (Pubitemid 43795188)
140. Berzat, A. C., J. E. Buss, E. J. Chenette, C. A. Weinbaum, A. Shutes, C. J. Der, A. Minden & A. D. Cox: Transforming activity of the Rho family GTPase, Wrch-1, a Wnt-regulated Cdc42 homolog, is dependent on a novel carboxyl-terminal palmitoylation motif. J Biol Chem, 280, 33055-33065 (2005) (Pubitemid 41368355)
141. Chen, C. A. & D. R. Manning: Regulation of G proteins by covalent modification. Oncogene, 20, 1643-1652 (2001) (Pubitemid 32336853)
142. Choy, E., V. K. Chiu, J. Silletti, M. Feoktistov, T. Morimoto, D. Michaelson, I. E. Ivanov & M. R. Philips: Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi. Cell, 98, 69-80 (1999) (Pubitemid 29331197)
143. Apolloni, A., I. A. Prior, M. Lindsay, R. G. Parton & J. F. Hancock: H-ras but not K-ras traffics to the plasma membrane through the exocytic
144. Goodwin, J. S., K. R. Drake, C. Rogers, L. Wright, J. Lippincott-Schwartz, M. R. Philips & K. Kenworthy: Depalmitoylated Ras traffics to and from the Golgi complex by a non vesicular pathway. J Cell Biol, 170, 261-272 (2005) (Pubitemid 41043808)
145. Ihara, K., S. Muraguchi, M. Kato, T. Shimizu, M. Shirakawa, S. Kuroda, K. Kaibuchi & T. Hakoshima: Crystal structure of human RhoA in a dominantly active form complexed with a GTP analogue. J Biol Chem, 273, 9656-9666 (1998) (Pubitemid 28183055)
146. Zalcman, G., V. Closson, J. Camonis, N. Honore, M. F. Rousseau-Merck, A. Tavitian & B. Olofsson: RhoGDI-3 is a new GDP dissociation inhibitor (GDI). Identification of a non-cytosolic GDI protein interacting with the small GTP-binding proteins RhoB and RhoG. J Biol Chem, 271, 30366-30374 (1996)
147. Michaelson, D., J. Silletti, G. Murphy, P. D'Eustachio, M. Rush & M. R. Philips: Differential localization of Rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding. J Cell Biol, 152, 111-126 (2001) (Pubitemid 32102441)
148. Gupta, P., A. A. Soyombo, A. Atashband, K. E. Wisniewski, J. M. Shelton, J. A. Richardson, R. E. Hammer & S. L. Hofmann: Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Proc Natl Acad Sci U S A, 98, 13566-13571 (2001) (Pubitemid 33115938)
149. Mukai, J., H. Liu, R. A. Burt, D. E. Swor, W. S. Lai, M. Karayiorgou & J. A. Gogos: Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat Genet, 36, 725-731 (2004) (Pubitemid 38886634)
150. Bivona, T. G., S. E. Quatela, B. O. Bodemann, I. M. Ahearn, M. J. Soskis, A. Mor, J. Miura, H. H. Wiener, L. Wright, S. G. Saba, D. Yim, A. Fein, I. Perez de Castro, C. Li, C. B. Thompson, A. D. Cox & M. R. Philips: PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis. Mol Cell, 21, 481-493 (2006) (Pubitemid 43228004)
151. Lander, H. M., D. P. Hajjar, B. L. Hempstead, U. A. Mirza, B. T. Chait, S. Campbell & L. A. Quilliam: A molecular redox switch on p21ras. Structural basis for the nitric oxide-p21ras interaction. J. Biol. Chem., 272, 4323-4326 (1997) (Pubitemid 27078505)
152. Mallis, R. J., J. E. Buss & J. A. Thomas: Oxidative modification of H-ras: S-thiolation and S-nitrosylation of reactive cysteines. Biochem J, 355, 145-153 (2001) (Pubitemid 32304245)
153. Heo, J. & S. L. Campbell: Superoxide anion radical modulates the activity of Ras and Ras-related GTPases by a radical-based mechanism similar to that of nitric oxide. J Biol Chem, 280, 12438-12445 (2005)
154. Baker, T. L., M. A. Booden & J. E. Buss: S-Nitrosocysteine increases palmitate turnover on Ha-Ras in NIH 3T3 cells. J Biol Chem, 275, 22037-22047 (2000) (Pubitemid 30621781)
155. Zmijewski, J. W., A. Landar, N. Watanabe, D. A. Dickinson, N. Noguchi & V. M. Darley-Usmar: Cell signalling by oxidized lipids and the role of reactive oxygen species in the endothelium. Biochem Soc Trans, 33, 1385-1389 (2005) (Pubitemid 41779694)
156. Shiraki, T., N. Kamiya, S. Shiki, T. S. Kodama, A. Kakizuka & H. Jingami: alpha, beta-Unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor. J Biol Chem, 280, 14145-14153 (2005) (Pubitemid 40517317)
157. Ceaser, E. K., D. R. Moellering, S. Shiva, A. Ramachandran, A. Landar, A. Venkartraman, J. Crawford, R. Patel, D. A. Dickinson, E. Ulasova, S. Ji & V. M. Darley-Usmar: Mechanisms of signal transduction mediated by oxidized lipids: the role of the electrophileresponsive proteome. Biochem Soc Trans, 32, 151-155 (2004) (Pubitemid 38283038)
158. Oliva, J. L., D. Pérez-Sala, A. Castrillo, N. Martínez, F. J. Cañada, L. Boscá & J. M. Rojas: The cyclopentenone 15-deoxy-Delta12, 14-prostaglandin J2 binds to and activates H-Ras. Proc Natl Acad Sci USA, 100, 4772-4777 (2003) (Pubitemid 36469241)
159. Millán, O., D. Rico, H. Peinado, N. Zarich, K. Stamatakis, D. Pérez-Sala, J. M. Rojas, A. Cano & L. Boscá: Potentiation of tumor formation by topic administration of 15-deoxy-Delta12, 14-prostaglandin J2 in a model of skin carcinogenesis. Carcinogenesis, 27, 328-336 (2006) (Pubitemid 43159887)
160. Batthyany, C., F. J. Schopfer, P. R. Baker, R. Duran, L. M. Baker, Y. Huang, C. Cervenansky, B. P. Branchaud & B. A. Freeman: Reversible posttranslational modification of proteins by nitrated fatty acids in vivo. J Biol Chem, 281, 20450-20463 (2006) (Pubitemid 44065818)
161. Eguchi, N., T. Minami, N. Shirafuji, Y. Kanaoka, T. Tanaka, A. Nagata, N. Yoshida, Y. Urade, S. Ito & O. Hayaishi: Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc Natl Acad Sci USA, 96, 726-730 (1999) (Pubitemid 29061276)
162. Trivedi, S. G., J. Newson, R. Rajakariar, T. S. Jacques, R. Hannon, Y. Kanaoka, N. Eguchi, P. Colville-Nash & D. W. Gilroy: Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity. Proc Natl Acad Sci USA, 103, 5179-5184 (2006)
163. Fujimoto, K., S. Arakawa, Y. Shibaya, H. Miida, Y. Ando, H. Yasumo, A. Hara, M. Uchiyama, H. Iwabuchi, W. Takasaki, S. Manabe & T. Yamoto: Characterization of phenotypes in Gstm1-null mice by cytosolic and in vivo metabolic studies using 1, 2-dichloro-4-nitrobenzene. Drug Metab Dispos, 34, 1495-1501 (2006) (Pubitemid 44285390)
164. Chowdhury, U. K., R. A. Zakharyan, A. Hernandez, M. D. Avram, M. J. Kopplin & H. V. Aposhian: Glutathione-S-transferase-omega [MMA (V) reductase] knockout mice: enzyme and arsenic species concentrations in tissues after arsenate administration. Toxicol Appl Pharmacol, 216, 446-457 (2006) (Pubitemid 44584319)
165. Henderson, C. J., A. G. Smith, J. Ure, K. Brown, E. J. Bacon & C. R. Wolf: Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc Natl Acad Sci USA, 95, 5275-5280 (1998)
166. Leveille-Webster, C. R. & I. M. Arias: Mdr 2 knockout mice link biliary phospholipid deficiency with small bile duct destruction. Hepatology, 19, 1528-1531 (1994) (Pubitemid 24166478)
167. Schinkel, A. H., J. J. Smit, O. van Tellingen, J. H. Beijnen, E. Wagenaar, L. van Deemter, C. A. Mol, M. A. van der Valk, E. C. Robanus-Maandag, H. P. Te Riele & et al.: Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell, 77, 491-502 (1994) (Pubitemid 24153990)
168. Schinkel, A. H., U. Mayer, E. Wagenaar, C. A. Mol, L. van Deemter, J. J. Smit, M. A. van der Valk, A. C. Voordouw, H. Spits, O. van Tellingen, J. M. Zijlmans, W. E. Fibbe & P. Borst: Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drugtransporting) P-glycoproteins. Proc Natl Acad Sci USA, 94, 4028-4033 (1997) (Pubitemid 27180493)
169. Lagas, J. S., M. L. Vlaming, O. van Tellingen, E. Wagenaar, R. S. Jansen, H. Rosing, J. H. Beijnen & A. H. Schinkel: Multidrug resistance protein 2 is an important determinant of paclitaxel pharmacokinetics. Clin Cancer Res, 12, 6125-6132 (2006) (Pubitemid 44703778)
170. Dwivedi, S., R. Sharma, A. Sharma, P. Zimniak, J. D. Ceci, Y. C. Awasthi & P. J. Boor: The course of CCl4 induced hepatotoxicity is altered in mGSTA4-4 null (-/-) mice. Toxicology, 218, 58-66 (2006) (Pubitemid 41774672)
171. Yu, X., P. A. Egner, J. Wakabayashi, N. Wakabayashi, M. Yamamoto & T. W. Kensler: Nrf2-mediated induction of cytoprotective enzymes by 15-deoxy-Delta12, 14-prostaglandin J2 is attenuated by alkenal/one oxidoreductase. J Biol Chem, 281, 26245-26252 (2006) (Pubitemid 44401832)